TrialJournal of clinical psychopharmacology2012

A Randomized, placebo-controlled, crossover pilot trial of the oral selective NR2B antagonist MK-0657 in patients with treatment-resistant major depressive disorder.

Lobna Ibrahim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.